The copyright and Pharma: A Precarious Investment?

The history of Sildenafil presents a intricate picture for those considering investment. While the initial release generated significant gains, the end of its exclusive rights opened the avenue to cheaper competitors, dramatically diminishing sales. This creates a unique dilemma for firms depending on comparable blockbuster products, suggesting tha

read more

Viagra and Pharma : A Uncertain Investment ?

The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, generating billions in sales , its patent expiration more info created a deluge of knock-off medications, significantly eroding its dominance. While certain pharmaceutical companies may seek to capitalize on related

read more